Breast Neoplasms: all 12,820 studies
Page 85 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Bioinformation Therapy for Breast CancerCompletedNCT03240224Phase 2/3
- Assessment of TK006 in Patients With Breast Cancer-related Bone MetastasesStatus unknownNCT03239756Phase 1
- Nature Sounds as a Pain and Anxiety Reducing Strategy in Patients Undergoing Breast Core BiopsyActive, not recruitingNCT03238976Not applicable
- Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerWithdrawnNCT03238703Phase 4
- Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast CancerStatus unknownNCT03238495Phase 2
- Tissue Stresses of Cancer (Force Horizon 2020)Status unknownNCT03238144Phase 1/2
- Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer.CompletedNCT03236974Phase 1
- Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Prostate Cancer or Stage I-III Colorectal CancerCompletedNCT03233555Not applicable
- Purpose Project: Reclaiming Life Purpose After Breast Cancer (Feasibility Study)CompletedNCT03233334Not applicable
- A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)CompletedNCT03232593
- The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and VomitingCompletedNCT03232541Not applicable
- Use of Clorhexidine Dressings to Reduce Surgical Site Infections in Breast Cancer Surgery. A Controlled Clinical TrialCompletedNCT03229824Not applicable
- CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDOCompletedNCT03227328Phase 2
- Physical Exercise in the Quality of Life and Physical Fitness of Elderly Women With Breast CancerCompletedNCT03226782Not applicable
- Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast CancerTerminatedNCT03225547Phase 2
- Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast CancerCompletedNCT03221881Not applicable
- Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine TherapyTerminatedNCT03220178Phase 4
- The Swedish Two-County Trial of Mammography ScreeningCompletedNCT03217539Not applicable
- Intraoperative Radiation Therapy (IORT) in DCISActive, not recruitingNCT03216421Not applicable
- Study First Step to Virtual Breast Cancer LocalizationCompletedNCT03214419
- The EMPOwER Study Evaluating Multiparameter Gene Testing as a Predictor of Short Term Endocrine Therapy Response in Hormone Receptor Positive Breast CancersStatus unknownNCT03211572Phase 2
- Implications of MEDIcal Low Dose RADiation Exposure - BReast Cancer Acute Coronary EventsCompletedNCT03211442
- Retrospective Observational Study About Evolution of Patients With Breast Cancer in Hospitals From GEICAM GroupCompletedNCT03210974
- Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment in Patients Affected by Breast CancerStatus unknownNCT03210441
- Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related LymphedemaCompletedNCT03210311Not applicable
- Motivational Interviewing to Increase Physical Activity Behaviour in Cancer PatientsCompletedNCT03210129Not applicable
- Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast CancerCompletedNCT03207529Phase 1
- Automated Quantification of Coronary Artery Calcifications on Radiotherapy Planning CTs for Cardiovascular Risk Prediction in Breast Cancer Patients: the BRAGATSTON StudyCompletedNCT03206333
- Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast CancerStatus unknownNCT03204734Phase 2
- Open Technique Interpectoral Catheter for Postoperative Analgesia in Modified Radical MastectomyCompletedNCT03204708Not applicable
- Kadcyla In pAtients With bRAin MetastasisWithdrawnNCT03203616Phase 2
- The Efficacy of Fulvestrant in ESR1(Estrogen Receptor 1) Mutated Metastatic Breast CancerStatus unknownNCT03202862Phase 2
- Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast CancerTerminatedNCT03202446Phase 3
- Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine TherapyCompletedNCT03201913Phase 1
- Effects on the Personalized Rehabilitation Service in Patients With CancerStatus unknownNCT03200067Not applicable
- Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor MalignanciesCompletedNCT03199586Phase 1
- Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node BiopsyStatus unknownNCT03199560Phase 4
- Breast PET FeasibilityCompletedNCT03198442Not applicable
- Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer SurvivorsCompletedNCT03198286Not applicable
- Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer PatientsTerminatedNCT03197805Not applicable
- Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer SurvivorsCompletedNCT03196037Not applicable
- Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast CancerCompletedNCT03195192Not applicable
- Pilates and Dance to Breast Cancer Patients Undergoing TreatmentCompletedNCT03194997Not applicable
- Development of Personalized Health Care Service in Patients With Breast CancerCompletedNCT03194399Not applicable
- Current Value of Axillary Ultrasound in the Staging of Breast Cancer. Is BSGC Still Necessary?Status unknownNCT03193008
- Metformin and Simvastatin in Addition to FulvestrantStatus unknownNCT03192293Phase 2
- Development of Exercise Promotion Program Using a Mobile CommunityCompletedNCT03190720Not applicable
- Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast SurgeryCompletedNCT03188393Phase 2
- A Window of Opportunity Study of Methionine Deprivation in Triple Negative Breast CancerTerminatedNCT03186937Phase 2
- Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast CancerStatus unknownNCT03186599Not applicable
- Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma ResponsesWithdrawnNCT03185871Phase 2
- GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer SurvivorsTerminatedNCT03185169Early Phase 1
- Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBCCompletedNCT03184090Phase 2
- Safety and Efficiency of γδ T Cell Against Breast CancerCompletedNCT03183206Phase 1/2
- The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) TrialStatus unknownNCT03182634Phase 2
- Breast Cancer Risk Assessment in Women Aged 40-49CompletedNCT03180086Not applicable
- Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast CancerCompletedNCT03176979Not applicable
- Health Benefits of HIT for Breast Cancer PatientsWithdrawnNCT03176888Not applicable
- QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based ChemotherapyWithdrawnNCT03175666Phase 1/2
- Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast CancerStatus unknownNCT03175341Phase 1/2
- 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in PatientsActive, not recruitingNCT03168737Phase 1
- Phase II Study of Single Agent LenvatinibStatus unknownNCT03168074Phase 2
- PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast CancerCompletedNCT03166085Phase 1
- Effect of Interval Cancer and Screening Process on Survival and Disease-free Period in Breast CancerCompletedNCT03165006
- Atezolizumab Combined with Immunogenic Chemotherapy in Patients with Metastatic Triple-negative Breast CancerCompletedNCT03164993Phase 2
- Onco4D(TM) Biodynamic Chemotherapy Selection for Breast Cancer PatientsStatus unknownNCT03164863
- First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-PeptideActive, not recruitingNCT03164486Early Phase 1
- The Role of Magnetic Resonance Imaging in Assessment of Axillary Lymph Nodes Metastasis in Breast Cancer Patients.CompletedNCT03163316
- Selumetinib and Olaparib in Solid TumorsActive, not recruitingNCT03162627Phase 1
- Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor TherapyCompletedNCT03162133Not applicable
- Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast CancerWithdrawnNCT03161834
- Improving Surgical/Medical Oncology Collaboration for Breast Cancer Treatment Planning: Pilot Testing the Impact of Continuing Education and Patient Care PlanningCompletedNCT03161600Not applicable
- Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy.Active, not recruitingNCT03161353Phase 2
- iMETX (Individualized Metabolic RX): a Pilot StudyCompletedNCT03158519Not applicable
- Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving AnthracyclinesStatus unknownNCT03155802
- DCb (Docetaxel/Carboplatin) Versus EC-D (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast CancerCompletedNCT03154749Phase 2
- Female Sexual Dysfunction in Breast Cancer PatientsStatus unknownNCT03153631
- Study of the Pharmacokinetics and Safety of Trastuzumab Emtansine in Chinese Participants With Locally Advanced Inoperable or Metastatic HER2+ Breast CancerCompletedNCT03153163Phase 1
- Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast CancerStatus unknownNCT03151447Phase 1
- A "Window Trial" on Boswellia for Breast Cancer Primary TumorsCompletedNCT03149081Phase 1
- Advanced Breast Cancer and Lifestyle Exercise StudyCompletedNCT03148886Not applicable
- Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast CancerStatus unknownNCT03147963Phase 2
- Early Detection of Breast Cancer in Women With Suspicious MammogramsActive, not recruitingNCT03147430
- AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast CancerTerminatedNCT03147040Phase 2
- A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer PatientsStatus unknownNCT03145961Phase 2
- Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer PatientsStatus unknownNCT03144947Phase 2
- 18F-FSPG PET/CT Imaging in Patients With CancersStatus unknownNCT03144622
- Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase InhibitorsCompletedNCT03144037
- Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only MetastasesActive, not recruitingNCT03143322Not applicable
- Decision Aid Website in Helping to Make Decisions About Fertility in Participants With CancerActive, not recruitingNCT03141437Not applicable
- TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast CancerCompletedNCT03140553Phase 2
- Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic CyclophosphamideCompletedNCT03139851Phase 2
- A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）Status unknownNCT03137368Phase 3
- Pharmacokinetics of SPI-2012 (Eflapegrastim) in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) ChemotherapyCompletedNCT03135951Phase 1
- Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation TherapyCompletedNCT03135782Not applicable
- Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to TrastuzumabCompletedNCT03135171Phase 1
- Young Breast Cancer Cohort StudyStatus unknownNCT03131089
- Body-image Satisfaction Following Permanent Black or Invisible UV Ink TattoosTerminatedNCT03131011Not applicable
- Comparison of Two Types of Biopsy in Suspicious Axillary Lymph NodesSuspendedNCT03130946Not applicable
- Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast CancerTerminatedNCT03128619Phase 1